Japan: Examining the first biosimilar patent litigation

In Japan, effectiveness and efficacy have been observed in breast cancer where overexpression of HER 2 was seen and in unresectable advanced or recurrent gastric cancer where overexpression of HER 2 w…
( read original story …)

---